Hitonam 500
Aztreonam 500mg
| Packing | Vial Tray Pack |
|---|
Hitonam 500 Injection is a prescription antibiotic containing Aztreonam 500 mg as its active ingredient. Aztreonam belongs to a class of antibiotics known as monobactams, a distinct group of beta-lactam drugs that differ structurally from penicillins and cephalosporins, making them a suitable option for patients who require targeted gram-negative coverage but cannot tolerate other beta-lactam antibiotics. Hitonam 500 is manufactured to consistent pharmaceutical standards and is intended strictly for use under medical supervision.
Hitonam 500 works by binding to specific proteins involved in bacterial cell wall synthesis, preventing the bacteria from building and maintaining a stable cell wall. This disruption weakens the bacterial structure, ultimately causing the cell to break down and die. Because of this mechanism, Aztreonam is primarily active against aerobic gram-negative organisms, while generally having little effect on gram-positive bacteria or anaerobes, allowing it to be used with a relatively focused spectrum of activity and a lower risk of disturbing the body’s normal bacterial flora compared with broader-spectrum antibiotics.
Hitonam 500 is commonly used to treat mild to moderate infections caused by susceptible gram-negative bacteria. This includes urinary tract infections, lower respiratory tract infections, skin and skin-structure infections, and select intra-abdominal infections. This lower-strength formulation is often chosen for less severe presentations, for patients requiring dose adjustment due to reduced kidney function, or as part of a stepped or de-escalation treatment plan after initial higher-dose therapy. In cases involving mixed infections with both gram-negative and gram-positive organisms, Hitonam 500 may be combined with other antibiotics to provide broader coverage, based on the treating physician’s clinical judgment.
Hitonam 500 is administered by a trained healthcare professional through intravenous (IV) or intramuscular (IM) injection, typically in a hospital or clinical setting, and is not intended for self-administration or home use. The exact dose, frequency, and duration of treatment are determined by the prescribing physician based on the severity of the infection, the patient’s kidney function, age, and overall clinical condition. As with any antibiotic, the full course of treatment should be completed even if symptoms improve early, in order to fully clear the infection and reduce the risk of antibiotic resistance developing.
Patients should inform their doctor of any known drug allergies, existing kidney or liver conditions, and all other medications or supplements being taken before starting treatment with Hitonam 500, as this information may affect dosing and safety monitoring. Aztreonam has a distinct chemical structure compared with penicillins and cephalosporins and generally shows minimal cross-reactivity, but any decision to use it in patients with known beta-lactam allergies should be made carefully by a physician. Use during pregnancy or breastfeeding should only occur if clearly needed and under direct medical guidance. Patients should promptly report any unusual symptoms, such as rash, breathing difficulty, or signs of an allergic reaction, to their healthcare provider.
Hitonam 500 is used to treat mild to moderate bacterial infections caused by susceptible gram-negative organisms, including urinary tract infections, lower respiratory tract infections, and skin and skin-structure infections.
It is given as an intravenous (IV) or intramuscular (IM) injection by a trained healthcare professional and is not intended for self-administration or home use.
Each vial of Hitonam 500 contains Aztreonam 500 mg, a monobactam-class antibiotic that works by inhibiting bacterial cell wall synthesis.
Both contain the same active ingredient, Aztreonam, but Hitonam 500 is a lower-strength formulation typically used for milder infections and in patients who need a reduced dose, such as those with impaired kidney function, while Hitonam 2000 is generally reserved for more severe infections.
Aztreonam has a distinct chemical structure compared to penicillins and cephalosporins and generally shows minimal cross-reactivity, which is why it is sometimes considered for patients with penicillin allergies. This decision should always be made by a physician based on the patient’s individual allergy history.
Common side effects may include injection site pain or swelling, nausea, vomiting, diarrhea, skin rash, and mild elevations in liver enzymes. Any unusual or severe reaction should be reported to a doctor immediately.
Aztreonam should only be used during pregnancy or breastfeeding if clearly needed and prescribed by a doctor, who will weigh the potential benefits against any risks based on the individual clinical situation.
Yes, Hitonam 500 is a prescription-only medicine and must be administered under the supervision of a qualified healthcare provider.
Patients should inform their doctor about any allergies, existing kidney or liver conditions, and all other medications or supplements being taken, since dosage may need to be adjusted, particularly for patients with reduced kidney function.
Yes, it is sometimes prescribed alongside other antibiotics to provide broader coverage for infections involving multiple types of bacteria, based on the treating physician’s clinical judgment.
+91 98557 72237
+91 94646 49052
info@diyahealthcare.com
Plot No. 46, Near Passport Office Industrial Area, Phase 2 Chandigarh – 160002